ask="1.74"
ask_size="1000"
average_daily_volume="45170"
bid="1.46"
bid_size="500"
book_value="0.69"
change="+0.03"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="-0.14"
change_from_52_week_high="-1.70"
change_From_52_week_low="0.38"
change_in_percent="+1.91%"
close="1.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.24"
ebitda="-6.29M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2852000"
high="1.64"
high_52_weeks="3.30"
last_trade_date="3/17/2017"
last_trade_price="1.60"
last_trade_size="363"
last_trade_time="4:00pm"
low="1.35"
low_52_weeks="1.22"
market_capitalization="17.58M"
moving_average_200_day="1.64"
moving_average_50_day="1.74"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.53"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.46%"
percent_change_from_50_day_moving_average="-7.88%"
percent_change_from_52_week_high="-51.52%"
percent_change_from_52_week_low="+31.15%"
previous_close="1.57"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.29"
price_per_sales="4.90"
revenue="3.52M"
shares_outstanding="10987000"
short_ratio="0.18"
stock_exchange="NCM"
symbol="CBLI"
volume="54474"
weeks_range_52="1.22 - 3.30"
